共有 50 笔近期内部人交易记录记录，涉及 Bio-Techne Corporation (TECH), 包括 19 笔买入 和 29 笔卖出. 内部人买入总额为 $3.39M 内部人卖出总额为 $13.82M.
近期活跃的重要内部人包括 Crouse Steven C., Herr Amy E., Mcmanus Matthew. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — TECH
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-02 |
Crouse Steven C. |
President - Diag & Spatial Bi |
限制性股票授予 (RSU) |
735 |
- |
- |
735 |
| 2026-03-01 |
Crouse Steven C. |
President - Diag & Spatial Bi |
未知 |
19,151 |
$53.60 |
$1.03M |
- |
| 2026-02-17 |
Herr Amy E. |
Director |
知情卖出 |
1,976 |
$59.11 |
$116.79K |
200 |
| 2026-02-03 |
Herr Amy E. |
Director |
期权行权（卖出） |
38 |
- |
- |
77 |
| 2026-02-01 |
Mcmanus Matthew |
President - Diag & Spatial Bio |
期权行权（卖出） |
4,621 |
- |
- |
4,620 |
| 2025-11-03 |
Hippel James |
CFO |
期权行权（卖出） |
13,159 |
- |
- |
- |
| 2025-11-03 |
Kelderman Kim |
Chief Executive Officer |
RSU 预扣税 |
2,303 |
$62.57 |
$144.1K |
48,665 |
| 2025-11-03 |
Geist William |
President, Protein Sciences |
期权行权（卖出） |
9,911 |
- |
- |
- |
| 2025-10-30 |
Higgins John L |
Director |
限制性股票授予 (RSU) |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Baumgartner Robert V |
Director |
限制性股票授予 (RSU) |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Keegan Joseph D |
Director |
限制性股票授予 (RSU) |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Bushman Julie L |
Director |
限制性股票授予 (RSU) |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Vessey Rupert |
Director |
限制性股票授予 (RSU) |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Seth Alpna |
Director |
限制性股票授予 (RSU) |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Klimovsky Judith V. |
Director |
限制性股票授予 (RSU) |
3,777 |
$60.96 |
$230.25K |
3,777 |
| 2025-10-30 |
Herr Amy E. |
Director |
限制性股票授予 (RSU) |
1,640 |
- |
- |
2,680 |
| 2025-08-25 |
Baumgartner Robert V |
Director |
期权行权（卖出） |
17,040 |
$21.84 |
$372.15K |
- |
| 2025-08-25 |
Nusse Roeland |
Director |
期权行权（卖出） |
17,040 |
$21.84 |
$372.15K |
- |
| 2025-08-15 |
Hippel James |
CFO |
期权行权（卖出） |
4,010 |
- |
- |
8,021 |
| 2025-08-15 |
Kelderman Kim |
Chief Executive Officer |
期权行权（卖出） |
8,543 |
- |
- |
17,087 |
| 2025-08-15 |
Geist William |
President, Protein Sciences |
期权行权（卖出） |
2,623 |
- |
- |
5,246 |
| 2025-08-15 |
Mcmanus Matthew |
President - Diag & Spatial Bio |
RSU 预扣税 |
880 |
$53.60 |
$47.17K |
4,735 |
| 2025-08-15 |
Bohnen Shane |
SVP - General Counsel |
期权行权（卖出） |
50 |
- |
- |
49 |
| 2025-08-15 |
Herr Amy E. |
Director |
期权行权（卖出） |
119 |
- |
- |
118 |
| 2025-08-07 |
Higgins John L |
Director |
期权行权（卖出） |
5,040 |
$21.84 |
$110.07K |
- |
| 2025-07-29 |
Hippel James |
CFO |
期权行权（卖出） |
168,620 |
$44.33 |
$7.47M |
- |
| 2025-07-22 |
Kelderman Kim |
Chief Executive Officer |
期权行权（卖出） |
48,176 |
$44.33 |
$2.14M |
- |
| 2025-07-15 |
Kelderman Kim |
Chief Executive Officer |
RSU 预扣税 |
32,933 |
$51.42 |
$1.69M |
42,203 |
| 2025-06-09 |
Herr Amy E. |
Director |
期权行权（卖出） |
1,280 |
$44.33 |
$56.74K |
- |
| 2025-05-01 |
Higgins John L |
Director |
期权行权（卖出） |
12,000 |
$21.84 |
$262.08K |
5,040 |
| 2025-04-03 |
Bohnen Shane |
SVP - General Counsel |
期权行权（卖出） |
2,260 |
- |
- |
2,259 |
| 2025-02-14 |
Herr Amy E. |
Director |
期权行权（卖出） |
1,976 |
$44.33 |
$87.6K |
1,280 |
| 2025-02-03 |
Herr Amy E. |
Director |
限制性股票授予 (RSU) |
115 |
- |
- |
115 |
| 2025-02-01 |
Geist William |
President, Protein Sciences |
期权行权（卖出） |
3,320 |
- |
- |
- |
| 2025-02-01 |
Mcmanus Matthew |
President - Dgs |
RSU 预扣税 |
1,642 |
$73.55 |
$120.77K |
2,978 |
| 2025-02-01 |
Herr Amy E. |
Director |
未知 |
480 |
- |
- |
- |
| 2025-01-27 |
Kelderman Kim |
Chief Executive Officer |
期权行权（卖出） |
13,392 |
$37.70 |
$504.88K |
- |
| 2024-11-01 |
Hippel James |
CFO |
期权行权（卖出） |
13,159 |
- |
- |
13,159 |
| 2024-11-01 |
Kelderman Kim |
Chief Executive Officer |
RSU 预扣税 |
2,430 |
$75.31 |
$183K |
39,004 |
| 2024-11-01 |
Geist William |
President, Protein Sciences |
期权行权（卖出） |
9,912 |
- |
- |
9,911 |
| 2024-10-24 |
Higgins John L |
Director |
限制性股票授予 (RSU) |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Baumgartner Robert V |
Director |
限制性股票授予 (RSU) |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Keegan Joseph D |
Director |
限制性股票授予 (RSU) |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Nusse Roeland |
Director |
限制性股票授予 (RSU) |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Bushman Julie L |
Director |
限制性股票授予 (RSU) |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Vessey Rupert |
Director |
限制性股票授予 (RSU) |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Seth Alpna |
Director |
限制性股票授予 (RSU) |
3,511 |
$68.37 |
$240.05K |
3,511 |
| 2024-10-24 |
Klimovsky Judith V |
Director |
限制性股票授予 (RSU) |
1,462 |
- |
- |
2,142 |
| 2024-09-12 |
Higgins John L |
Director |
期权行权（卖出） |
6,000 |
$22.95 |
$137.7K |
- |
| 2024-08-29 |
Kelderman Kim |
Chief Executive Officer |
期权行权 |
1,492 |
$66.97 |
$99.92K |
41,434 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
